Table 2.
Variables | Upper Class | Middle Class | Working class | Total | |||||
---|---|---|---|---|---|---|---|---|---|
– | n | % | n | % | n | % | n | % | |
Infected people | Female | 7,683 | 45.16 | 14,384 | 43.61 | 4,000 | 44.66 | 32,874 | 55.76 |
Male | 9,330 | 54.84 | 18,598 | 56.39 | 4,956 | 55.34 | 26,077 | 44.24 | |
Total | 17,013 | 100 | 32,982 | 100 | 8,956 | 100 | 58,951 | 100 | |
Infected people in age group | 0–14 | 300 | 1.76 | 810 | 2.46 | 321 | 3.58 | 1,429 | 2.42 |
15–64 | 14,282 | 83.95 | 27,593 | 83.66 | 7,112 | 79.41 | 48,996 | 83.11 | |
+65 | 2,431 | 14.29 | 4,579 | 13.88 | 1,523 | 17 | 8,526 | 14.46 | |
Total | 17,031 | 100 | 32,982 | 100 | 8,956 | 100 | 58,951 | 100 | |
Prevalence per 100,000 population in age groups | 0–14 | 946.9 | 771.4 | 597.5 | 750.5 | ||||
15–64 | 9818.3 | 7605.4 | 8150.8 | 6579.0 | |||||
+65 | 63872.8 | 89433.5 | 119732.7 | 116237.2 | |||||
Prevalence per 100,000 population based on gender | Female | 8296.7 | 5534.1 | 6398.9 | 6956.2 | ||||
Male | 10603.8 | 7152.0 | 7656.5 | 5549.7 | |||||
Total | 9420.7 | 6343.2 | 3702.0 | 6254.9 | |||||
Total population | Female | 92,603 | 259,916 | 120,066 | 472,585 | ||||
Male | 87,987 | 260,037 | 121,856 | 469,880 | |||||
Total | 180,590 | 519,953 | 241,922 | 942,465 | |||||
0–14 | 31,680 | 105,002 | 53,724 | 190,406 | |||||
15–64 | 145,462 | 411,500 | 87,255 | 744,724 | |||||
+65 | 3,806 | 5,120 | 1,272 | 7,335 |